Topics
News
CME/CE
Editorial Advisory Board
Partnerships
Melanoma immunotherapy trial shows some improvement in survival
London - Researchers in Australia reporting on an immunotherapy trial with vaccinia viral melanoma cell lysates in patients with stage IIb and III melanoma say that finding an effective adjuvant treatment for melanoma is proving to be a challenge.
Related Videos
Related Content
